EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of COVID ‐19 Pandemic on Epidemiology and Antimicrobial Susceptibility of Campylobacter Species, Salmonella enterica and Yersinia enterocolitica in Southwest Finland 2018–2022

Tanja Orpana, Teemu Kallonen, Antti J Hakanen, Marianne Gunell iD

APMIS · 2026-03 · 134 (3)

DOI: 10.1111/apm.70187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, online erschienen am 13.03.2026. Verfasst von Tanja Orpana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedicine, University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Salmonella enterica, Yersinia enterocolitica, Anti-Bacterial Agents, Campylobacter. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the effect of the COVID‐19 pandemic on the epidemiology and antimicrobial susceptibility of fecal Campylobacter spp. , Salmonella enterica , and Yersinia enterocolitica strains in Southwest Finland from 2018 to 2022. Results show that the number of travel‐associated S. enterica and Campylobacter spp. declined markedly from autumn 2019 to autumn 2020 and have recovered gradually. Antimicrobial susceptibility testing was performed on bacterial strains isolated from PCR‐positive fecal specimens. Resistance patterns fluctuated throughout the study period. Among C. jejuni , ciprofloxacin resistance averaged 58% in domestic ( n = 155) and 88% travel‐associated ( n = 10) strains, while tetracycline resistance averaged 36% and 63%, respectively; erythromycin resistance was not detected. In S. enterica , resistance averaged 42% and 33% to ampicillin, 33% and 45% to fluoroquinolones, 4% and 6% to cefotaxime, and 0% and 2% to co‐trimoxazole, in domestic ( n = 24) and travel‐associated ( n = 32) strains, respectively. Among domestic Y. enterocolitica strains ( n = 64), resistance averaged 7% to co‐trimoxazole, 2% to ciprofloxacin, and 1% to cefotaxime; no travel‐associated strains were reported. This study shows that lockdowns due to the COVID‐19 pandemic decreased the number of diagnosed enteropathogens and limited the emergence of resistant strains. Thus, our results reaffirm that travel remains the primary source of S. enterica infections in Finland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salmonella entericaYersinia enterocoliticaAnti-Bacterial AgentsCampylobacterCOVID-19Campylobacter InfectionsYersinia InfectionsFinlandHumansMicrobial Sensitivity TestsDrug Resistance, BacterialFecesCiprofloxacinPandemicsFluoroquinolones

Stichwörter der Autor:innen

Yersiniaantimicrobial resistancecampylobacterenteropathogenssalmonella

Substanzen

Anti-Bacterial AgentsCiprofloxacinFluoroquinolones

Autor:innen und Institutionen

  • Institute of Biomedicine, University of Turku, Turku, Finland.
  • Turku Clinical Microbiome Bank, Clinical Microbiology, Turku University Hospital, the Wellbeing Services County of Southwest Finland, Turku, Finland.

ORCID-Profile: Marianne Gunell

Zitieren

APA

Orpana, T., Kallonen, T., Hakanen, A. J., & Gunell, M. (2026). Effect of COVID ‐19 Pandemic on Epidemiology and Antimicrobial Susceptibility of Campylobacter Species, Salmonella enterica and Yersinia enterocolitica in Southwest Finland 2018–2022. APMIS, 134(3). https://doi.org/10.1111/apm.70187

Vancouver

Orpana T, Kallonen T, Hakanen AJ, Gunell M. Effect of COVID ‐19 Pandemic on Epidemiology and Antimicrobial Susceptibility of Campylobacter Species, Salmonella enterica and Yersinia enterocolitica in Southwest Finland 2018–2022. APMIS. 2026;134(3). doi:10.1111/apm.70187

BibTeX
@article{Orpana2026,
  author = {Orpana, Tanja and Kallonen, Teemu and Hakanen, Antti J and Gunell, Marianne},
  title = {Effect of COVID ‐19 Pandemic on Epidemiology and Antimicrobial Susceptibility of Campylobacter Species, Salmonella enterica and Yersinia enterocolitica in Southwest Finland 2018–2022},
  journal = {APMIS},
  year = {2026},
  volume = {134},
  number = {3},
  doi = {10.1111/apm.70187}
}
Kostenlos starten →